Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Karoum

Showing results (41-50 of 148) with videos related to

Pageof 15
Sort By:
British Journal of Pharmacology|July 1, 1980
Differential sensitivity of hypothalamic dopaminergic and noradrenergic neurones to pharmacological manipulationF Karoum, S G Speciale, R J Wyatt
European Journal of Pharmacology|August 15, 1977
The dynamics of dopamine metabolism in various regions of rat brainF Karoum, N H Neff, R J Wyatt
Psychopharmacology Bulletin|January 1, 1980
Phenylethylamine (PEA) and phenylacetic acid (PAA) in the urine of chronic schizophrenic patients and controlsS G Potkin, R J Wyatt, F Karoum
European Journal of Pharmacology|July 16, 1982
Different effects of behaviorally equipotent doses of amphetamine and methamphetamine on brain biogenic amines: specific increase of phenylethylamine by amphetamineL W Chuang, F Karoum, R J Wyatt
British Journal of Pharmacology|November 1, 1981
A study on the acute effect of amphetamine on the urinary excretion of biogenic amines and metabolites in monkeysL W Chuang, F Karoum, M J Perlow
Neuroscience|January 1, 1981
Effects of hypoxia lasting up to one month on the catecholamine content in rat carotid bodyI Hanbauer, F Karoum, S Hellstrom, et al.
American Journal of Therapeutics|July 29, 1999
Effects of the administration of amphetamine, either alone or in combination with reserpine or cocaine, on regional brain beta-phenylethylamine and dopamine releaseF Karoum, M E Wolf, A D Mosnaim
Behavioural Pharmacology|April 26, 2000
SR 141716A, a CB1 cannabinoid receptor antagonist, potentiates the locomotor stimulant effects of amphetamine and apomorphineJ M Masserano, F Karoum, R J Wyatt
European Journal of Pharmacology|March 11, 1994
Selective reduction in dopamine turnover in the rat frontal cortex and hypothalamus during withdrawal from repeated cocaine exposureF Karoum, M F Egan, R J Wyatt
Biochemical Pharmacology|January 1, 1980
3,4-dihydroxyphenylacetic acid content of sympathetic ganglia as a possible biochemical indicator of small intensely fluorescent cell participation in ganglionic transmissionF Karoum, S G Speciale, N H Neff
Pageof 15

Showing results (41-50 of 148) with videos related to

Sort By:
Pageof 15
British Journal of Pharmacology|July 1, 1980
Differential sensitivity of hypothalamic dopaminergic and noradrenergic neurones to pharmacological manipulationF Karoum, S G Speciale, R J Wyatt
European Journal of Pharmacology|August 15, 1977
The dynamics of dopamine metabolism in various regions of rat brainF Karoum, N H Neff, R J Wyatt
Psychopharmacology Bulletin|January 1, 1980
Phenylethylamine (PEA) and phenylacetic acid (PAA) in the urine of chronic schizophrenic patients and controlsS G Potkin, R J Wyatt, F Karoum
European Journal of Pharmacology|July 16, 1982
Different effects of behaviorally equipotent doses of amphetamine and methamphetamine on brain biogenic amines: specific increase of phenylethylamine by amphetamineL W Chuang, F Karoum, R J Wyatt
British Journal of Pharmacology|November 1, 1981
A study on the acute effect of amphetamine on the urinary excretion of biogenic amines and metabolites in monkeysL W Chuang, F Karoum, M J Perlow
Neuroscience|January 1, 1981
Effects of hypoxia lasting up to one month on the catecholamine content in rat carotid bodyI Hanbauer, F Karoum, S Hellstrom, et al.
American Journal of Therapeutics|July 29, 1999
Effects of the administration of amphetamine, either alone or in combination with reserpine or cocaine, on regional brain beta-phenylethylamine and dopamine releaseF Karoum, M E Wolf, A D Mosnaim
Behavioural Pharmacology|April 26, 2000
SR 141716A, a CB1 cannabinoid receptor antagonist, potentiates the locomotor stimulant effects of amphetamine and apomorphineJ M Masserano, F Karoum, R J Wyatt
European Journal of Pharmacology|March 11, 1994
Selective reduction in dopamine turnover in the rat frontal cortex and hypothalamus during withdrawal from repeated cocaine exposureF Karoum, M F Egan, R J Wyatt
Biochemical Pharmacology|January 1, 1980
3,4-dihydroxyphenylacetic acid content of sympathetic ganglia as a possible biochemical indicator of small intensely fluorescent cell participation in ganglionic transmissionF Karoum, S G Speciale, N H Neff
Pageof 15